Challenges and developments in research of the early stages of bipolar disorder

Revista Brasileira de Psiquiatria

Volumn 38, Issue 4, 2016, Pages 329-337

  Brietzke, Elisa ^a   Rosa, Adriane R ^b,c   Pedrini, Mariana ^a   Noto, Mariane Nunes ^a   Kapczinski, Flavio ^b,c   Scott, Jan ^d,e  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

At risk; Bipolar disorder; Early stages; Mania; Offspring; Prodromal

Indexed keywords

BIPOLAR DISORDER; COGNITION; DEPRESSION; DIFFUSION TENSOR IMAGING; HUMAN; MANIA; MENTAL HEALTH; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; COGNITION DISORDERS; DIAGNOSTIC IMAGING; DISEASE COURSE; EARLY DIAGNOSIS; MEDICAL RESEARCH; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

BIOLOGICAL MARKER;

BIOMARKERS; BIOMEDICAL RESEARCH; BIPOLAR DISORDER; COGNITION DISORDERS; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 84994626875     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2016-1975     Document Type: Review

References (101)

1. Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, et al. Stage managing bipolar disorder. Bipolar Disord. 2014; 16: 471-7.
2. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011; 35: 804-17.
3. Correll CU, Olvet DM, Auther AM, Hauser M, Kishimoto T, Carrion RE, et al. The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls. Bipolar Disord. 2014; 16: 505-22.
4. Bechdolf A, Ratheesh A, Cotton SM, Nelson B, Chanen AM, Betts J, et al. The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study. Bipolar Disord. 2014; 16: 493-504.
5. Correll CU, Hauser M, Penzner JB, Auther AM, Kafantaris V, Saito E, et al. Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode. Bipolar Disord. 2014; 16: 478-92.
6. Taylor M, Bressan RA, Pan Neto P, Brietzke E. Early intervention for bipolar disorder: current imperatives, future directions. Rev Bras Psiquiatr. 2011; 33: s197-212.
7. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008; 32: 675-92.
8. Abe C, Ekman CJ, Sellgren C, Petrovic P, Ingvar M, Landen M. Manic episodes are related to changes in frontal cortex: a longitudinal neuroimaging study of bipolar disorder 1. Brain. 2015; 138: 3440-8.
9. Brietzke E, Mansur RB, Soczynska JK, Kapczinski F, Bressan RA, McIntyre RS. Towards a multifactorial approach for prediction of bipolar disorder in at risk populations. J Affect Disord. 2012; 140: 82-91.
10. Walker AJ, Kim Y, Price JB, Kale RP, McGillivray JA, Berk M, et al. Stress, inflammation, and cellular vulnerability during early stages of affective disorders: biomarker strategies and opportunities for prevention and intervention. Front Psychiatry. 2014; 5: 34.
11. Roda A, Chendo I, Kunz M. Biomarkers and staging of bipolar disorder: a systematic review. Trends Psychiatry Psychother. 2015; 37: 3-11.
12. Gama CS, Kunz M, Magalhaes PV, Kapczinski F. Staging and neuroprogression in bipolar disorder: a systematic review of the literature. Rev Bras Psiquiatr. 2013; 35: 70-4.
13. Andreazza AC, Kauer-Sant’anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord. 2008; 111: 135-44.
14. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008; 63: 801-8.
15. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant’Anna M, Klamt F, et al. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry. 2010; 15: 784-6.
16. Kapczinski F, Dias VV, Kauer-Sant’Anna M, Brietzke E, Vazquez GH, Vieta E, et al. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33: 1366-71.
17. Hickie IB, Scott J, McGorry PD. Clinical staging for mental disorders: a new development in diagnostic practice in mental health. Med J Aust. 2013; 198: 461-2.
18. Scott J, Leboyer M, Hickie I, Berk M, Kapczinski F, Frank E, et al. Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry. 2013; 202: 243-5.
19. Kapczinski F, Dias VV, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, et al. Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother. 2009; 9: 957-66.
20. Grande I, Magalhaes PV, Kunz M, Vieta E, Kapczinski F. Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol Behav. 2012; 106: 46-50.
21. Scott J. Bipolar disorder: from early identification to personalized treatment. Early Interv Psychiatry. 2011; 5: 89-90.
22. Duffy A, Horrocks J, Doucette S, Keown-Stoneman C, Grof P, Andreazza A, et al. Immunological and neurotrophic markers of risk status and illness development in high-risk youth: understanding the neurobiological underpinnings of bipolar disorder. Int J Bipolar Disord. 2014; 2: 29.
23. Mesman E, Nolen WA, Reichart CG, Wals M, Hillegers MH. The Dutch bipolar offspring study: 12-year follow-up. Am J Psychiatry. 2013; 170: 542-9.
24. Brietzke E, Araripe Neto AG, Dias A, Mansur RB, Bressan RA. Early intervention in psychosis: a map of clinical and research initiatives in Latin America. Rev Bras Psiquiatr. 2011; 33: s213-24.
25. Gardsjord ES, Romm KL, Friis S, Barder HE, Evensen J, Haahr U, et al. Subjective quality of life in first-episode psychosis. A ten year follow-up study. Schizophr Res. 2016; 172: 23-8.
26. Grano N, Karjalainen M, Ranta K, Lindgren M, Roine M, Therman S. Community-oriented family-based intervention superior to standard treatment in improving depression, hopelessness and functioning among adolescents with any psychosis-risk symptoms. Psychiatry Res. 2016; 237: 9-16.
27. Brewer WJ, Lambert TJ, Witt K, Dileo J, Duff C, Crlenjak C, et al. Intensive case management for high-risk patients with first-episode psychosis: service model and outcomes. Lancet Psychiatry. 2015; 2: 29-37.
28. Fava GA, Kellner R. Prodromal symptoms in affective disorders. Am J Psychiatry. 1991; 148: 823-30.
29. Beiser M, Erickson D, Fleming JA, Iacono WG. Establishing the onset of psychotic illness. Am J Psychiatry. 1993; 150: 1349-54.
30. Singh MK. Is there validity to the bipolar prodrome?. J Clin Psychiatry. 2015; 76: e655-6.
31. Rios AC, Noto MN, Rizzo LB, Mansur R, Martins FE Jr, Grassi-Oliveira R, et al. Early stages of bipolar disorder: characterization and strategies for early intervention. Rev Bras Psiquiatr. 2015; 37: 343-9.
32. Passos IC, Jansen K, Kapczinski F. Developmental staging models in bipolar disorder. Int J Bipolar Disord. 2015; 3: 33.
33. Goetz M, Novak T, Vesela M, Hlavka Z, Brunovsky M, Povazan M, et al. Early stages of pediatric bipolar disorder: retrospective analysis of a Czech inpatient sample. Neuropsychiatr Dis Treat. 2015; 11: 2855-64.
34. Noto MN, Noto C, Caribe AC, Miranda-Scippa A, Nunes SO, Chaves AC, et al. Clinical characteristics and influence of childhood trauma on the prodrome of bipolar disorder. Rev Bras Psiquiatr. 2015; 37: 280-8.
35. Bellivier F, Golmard JL, Rietschel M, Schulze TG, Malafosse A, Preisig M, et al. Age at onset in bipolar I affective disorder: further evidence for three subgroups. Am J Psychiatry. 2003; 160: 999-1001.
36. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003; 289: 3095-105.
37. Egeland JA, Hostetter AM, Pauls DL, Sussex JN. Prodromal symptoms before onset of manic-depressive disorder suggested by first hospital admission histories. J Am Acad Child Adolesc Psychiatry. 2000; 39: 1245-52.
38. Fergus EL, Miller RB, Luckenbaugh DA, Leverich GS, Findling RL, Speer AM, et al. Is there progression from irritability/dyscontrol to major depressive and manic symptoms? A retrospective community survey of parents of bipolar children. J Affect Disord. 2003; 77: 71-8.
39. Rucklidge JJ. Retrospective parent report of psychiatric histories: do checklists reveal specific prodromal indicators for postpubertalonset pediatric bipolar disorder?. Bipolar Disord. 2008; 10: 56-66.
40. Skjelstad DV, Malt UF, Holte A. Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review. J Affect Disord. 2010; 126: 1-13.
41. Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, Hunt J, et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry. 2009; 166: 795-804.
42. Rasic D, Hajek T, Alda M, Uher R. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies. Schizophr Bull. 2014; 40: 28-38.
43. Scott J. [Beyond psychosis: the challenge of early intervention in bipolar disorders]. Rev Psiquiatr Salud Ment. 2012; 5: 1-4.
44. Wals M, Reichart CG, Hillegers MH, Van Os J, Verhulst FC, Nolen WA, et al. Impact of birth weight and genetic liability on psychopathology in children of bipolar parents. J Am Acad Child Adolesc Psychiatry. 2003; 42: 1116-21.
45. Hillegers MH, Burger H, Wals M, Reichart CG, Verhulst FC, Nolen WA, et al. Impact of stressful life events, familial loading and their interaction on the onset of mood disorders: study in a high-risk cohort of adolescent offspring of parents with bipolar disorder. Br J Psychiatry. 2004; 185: 97-101.
46. Loftus J, Etain B, Scott J. What can we learn from offspring studies in bipolar disorder?. Adv Psychiatr Treat. 2016; 22: 176-85.
47. Duffy A, Doucette S, Lewitzka U, Alda M, Hajek T, Grof P. Findings from bipolar offspring studies: methodology matters. Early Interv Psychiatry. 2011; 5: 181-91.
48. Nurnberger JI Jr, McInnis M, Reich W, Kastelic E, Wilcox HC, Glowinski A, et al. A high-risk study of bipolar disorder. Childhood clinical phenotypes as precursors of major mood disorders. Arch Gen Psychiatry. 2011; 68: 1012-20.
49. Birmaher B, Axelson D, Goldstein B, Monk K, Kalas C, Obreja M, et al. Psychiatric disorders in preschool offspring of parents with bipolar disorder: the Pittsburgh Bipolar Offspring Study (BIOS). Am J Psychiatry. 2010; 167: 321-30.
50. Henin A, Biederman J, Mick E, Sachs GS, Hirshfeld-Becker DR, Siegel RS, et al. Psychopathology in the offspring of parents with bipolar disorder: a controlled study. Biol Psychiatry. 2005; 58: 554-61.
51. Hammen C, Burge D, Burney E, Adrian C. Longitudinal study of diagnoses in children of women with unipolar and bipolar affective disorder. Arch Gen Psychiatry. 1990; 47: 1112-7.
52. Bechdolf A, Ratheesh A, Wood SJ, Tecic T, Conus P, Nelson B, et al. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr Pharm Des. 2012; 18: 358-75.
53. Malhi GS, Bargh DM, Coulston CM, Das P, Berk M. Predicting bipolar disorder on the basis of phenomenology: implications for prevention and early intervention. Bipolar Disord. 2014; 16: 455-70.
54. Chakrabarty T, Kozicky JM, Torres IJ, Lam RW, Yatham LN. Verbal memory impairment in new onset bipolar disorder: relationship with frontal and medial temporal morphology. World J Biol Psychiatry. 2015; 16: 249-60.
55. Torres IJ, Kozicky J, Popuri S, Bond DJ, Honer WG, Lam RW, et al. 12-month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder. Bipolar Disord. 2014; 16: 159-71.
56. Gignac A, McGirr A, Lam RW, Yatham LN. Recovery and recurrence following a first episode of mania: a systematic review and meta-analysis of prospectively characterized cohorts. J Clin Psychiatry. 2015; 76: 1241-8.
57. Daglas R, Yucel M, Cotton S, Allott K, Hetrick S, Berk M. Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness. Int J Bipolar Disord. 2015; 3: 9.
58. Trotta A, Murray RM, MacCabe JH. Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder? A systematic review and meta-analysis. Psychol Med. 2015; 45: 381-94.
59. Lee RS, Hermens DF, Scott J, Redoblado-Hodge MA, Naismith SL, Lagopoulos J, et al. A meta-analysis of neuropsychological functioning in first-episode bipolar disorders. J Psychiatr Res. 2014; 57: 1-11.
60. Lopez-Jaramillo C, Lopera-Vasquez J, Gallo A, Ospina-Duque J Bell V, Torrent C, et al. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord. 2010; 12: 557-67.
61. Nehra R, Chakrabarti S, Pradhan BK, Khehra N. Comparison of cognitive functions between first- and multi-episode bipolar affective disorders. J Affect Disord. 2006; 93: 185-92.
62. Torres IJ, DeFreitas VG, DeFreitas CM, Kauer-Sant’Anna M, Bond DJ, Honer WG, et al. Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry. 2010; 71: 1234-42.
63. Strakowski SM, Adler CM, Cerullo M, Eliassen JC, Lamy M, Fleck DE, et al. Magnetic resonance imaging brain activation in first-episode bipolar mania during a response inhibition task. Early Interv Psychiatry. 2008; 2: 225-33.
64. Lee W, Bindman J, Ford T, Glozier N, Moran P, Stewart R, et al. Bias in psychiatric case-control studies: literature survey. Br J Psychiatry. 2007; 190: 204-9.
65. Raust A, Daban C, Cochet B, Henry C, Bellivier F, Scott J. Neurocognitive performance as an endophenotype for bipolar disorder. Front Biosci (Elite Ed). 2014; 6: 89-103.
66. Ratheesh A, Cotton SM, Betts JK, Chanen A, Nelson B, Davey CG, et al. Prospective progression from high-prevalence disorders to bipolar disorder: exploring characteristics of pre-illness stages. J Affect Disord. 2015; 183: 45-8.
67. Bechdolf A, Nelson B, Cotton SM, Chanen A, Thompson A, Kettle J, et al. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. J Affect Disord. 2010; 127: 316-20.
68. Keener MT, Phillips ML. Neuroimaging in bipolar disorder: a critical review of current findings. Curr Psychiatry Rep. 2007; 9: 512-20.
69. Fusar-Poli P, Howes O, Bechdolf A, Borgwardt S. Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies. J Psychiatry Neurosci. 2012; 37: 170-84.
70. Lagopoulos J, Hermens DF, Hatton SN, Battisti RA, Tobias-Webb J, White D, et al. Microstructural white matter changes are correlated with the stage of psychiatric illness. Transl Psychiatry. 2013; 3: e248.
71. Martinot JL, Mana S. [Neuroimaging of psychiatric and pedopsychiatric disorders]. Med Sci (Paris). 2011; 27: 639-50.
72. Otten M, Meeter M. Hippocampal structure and function in individuals with bipolar disorder: a systematic review. J Affect Disord. 2015; 174: 113-25.
73. Silveira LE, Bond DJ, MacMillan EL, Kozicky JM, Muralidharan K, Bucker J, et al. Hippocampal neurochemical markers in bipolar disorder patients following the first-manic episode: a prospective 12-month proton magnetic resonance spectroscopy study. Aust N Z J Psychiatry 2016 Jan 20. pii: 0004867415623859 [Epub ahead of print].
74. Hajek T, Bauer M, Simhandl C, Rybakowski J, O’Donovan C, Pfennig A, et al. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychol Med. 2014; 44: 507-17.
75. Bonnin CM, Reinares M, Martinez-Aran A, Balanza-Martinez V, Sole B, Torrent C, et al. Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory. Psychol Med. 2016; 46: 291-301.
76. Torrent C, Bonnin Cdel M, Martinez-Aran A, Valle J, Amann BL, Gonzalez-Pinto A, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013; 170: 852-9.
77. Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, Mark M, et al. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry. 2002; 159: 2027-35.
78. Tiihonen J, Haukka J, Henriksson M, Cannon M, Kieseppa T, Laaksonen I, et al. Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. Am J Psychiatry. 2005; 162: 1904-10.
79. Zammit S, Allebeck P, David AS, Dalman C, Hemmingsson T, Lundberg I, et al. A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry. 2004; 61: 354-60.
80. Meyer SE, Carlson GA, Wiggs EA, Martinez PE, Ronsaville DS, Klimes-Dougan B, et al. A prospective study of the association among impaired executive functioning, childhood attentional problems, and the development of bipolar disorder. Dev Psychopathol. 2004; 16: 461-76.
81. Olvet DM, Stearns WH, McLaughlin D, Auther AM, Correll CU, Cornblatt BA. Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodrome. Schizophr Res. 2010; 123: 59-63.
82. Duffy A, Hajek T, Alda M, Grof P, Milin R, MacQueen G. Neurocognitive functioning in the early stages of bipolar disorder: visual backward masking performance in high risk subjects. Eur Arch Psychiatry Clin Neurosci. 2009; 259: 263-9.
83. Hellvin T, Sundet K, Simonsen C, Aminoff SR, Lagerberg TV, Andreassen OA, et al. Neurocognitive functioning in patients recently diagnosed with bipolar disorder. Bipolar Disord. 2012; 14: 227-38.
84. Rosa AR, Magalhaes PV, Czepielewski L, Sulzbach MV, Goi PD, Vieta E, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry. 2014; 75: e450-6.
85. Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord. 2006; 93: 105-15.
86. Kozicky JM, Torres IJ, Silveira LE, Bond DJ, Lam RW, Yatham LN. Cognitive change in the year after a first manic episode: association between clinical outcome and cognitive performance early in the course of bipolar I disorder. J Clin Psychiatry. 2014; 75: e587-93.
87. Martinez-Aran A, Scott J, Colom F, Torrent C, Tabares-Seisdedos R, Daban C, et al. Treatment nonadherence and neurocognitive impairment in bipolar disorder. J Clin Psychiatry. 2009; 70: 1017-23.
88. Berger GE, Wood SJ, Ross M, Hamer CA, Wellard RM, Pell G, et al. Neuroprotective effects of low-dose lithium in individuals at ultrahigh risk for psychosis. A longitudinal MRI/MRS study. Curr Pharm Des. 2012; 18: 570-5.
89. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999; 156: 1264-6.
90. Reinares M, Colom F, Rosa AR, Bonnin CM, Franco C, Sole B, et al. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010; 123: 81-6.
91. Brietzke E, Stertz L, Fernandes BS, Kauer-Sant’anna M, Mascarenhas M, Escosteguy Vargas A, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009; 116: 214-7.
92. McGorry PD. Early intervention in psychosis: obvious, effective, overdue. J Nerv Ment Dis. 2015; 203: 310-8.
93. Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry. 2008; 65: 395-407.
94. Scola G, McNamara RK, Croarkin PE, Leffler JM, Cullen KR, Geske JR, et al. Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder. J Affect Disord. 2016; 192: 176-83.
95. Alloy LB, Boland EM, Ng TH, Whitehouse WG, Abramson LY. Low social rhythm regularity predicts first onset of bipolar spectrum disorders among at-risk individuals with reward hypersensitivity. J Abnorm Psychol. 2015; 124: 944-52.
96. Zanini MA, Castro J, Cunha GR, Asevedo E, Pan PM, Bittencourt L, et al. Abnormalities in sleep patterns in individuals at risk for psychosis and bipolar disorder. Schizophr Res. 2015; 169: 262-7.
97. Castro J, Zanini M, Goncalves Bda S, Coelho FM, Bressan R, Bittencourt L, et al. Circadian rest-activity rhythm in individuals at risk for psychosis and bipolar disorder. Schizophr Res. 2015; 168: 50-5.
98. Kraemer HC, Schultz SK, Arndt S. Biomarkers in psychiatry: methodological issues. Am J Geriatr Psychiatry. 2002; 10: 653-9.
99. Scarr E, Millan MJ, Bahn S, Bertolino A, Turck CW, Kapur S, et al. Biomarkers for psychiatry: the journey from fantasy to fact, a report of the 2013 CINP think tank. Int J Neuropsychopharmacol. 2015; 18: pyv042.
100. McIntyre RS, Cha DS, Jerrell JM, Swardfager W, Kim RD, Costa LG, et al. Advancing biomarker research: utilizing ‘Big Data’ approaches for the characterization and prevention of bipolar disorder. Bipolar Disord. 2014; 16: 531-47.
101. Alawieh A, Zaraket FA, Li JL, Mondello S, Nokkari A, Razafsha M, et al. Systems biology, bioinformatics, and biomarkers in neuropsychiatry. Front Neurosci. 2012; 6: 187.